Article
Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma.
Cancer science - 1 Feb 2022
Nakano Tomoyuki, Fujimoto Kenji, Tomiyama Arata, Takahashi Masamichi, Achiha Takamune, Arita Hideyuki, Kawauchi Daisuke, Yasukawa Mami, Masutomi Kenkichi, Kondo Akihide, Narita Yoshitaka, Maehara Taketoshi, Ichimura Koichi
Abstract excerpt
Meningioma is the most common intracranial tumor, with generally favorable patient prognosis. However, patients with malignant meningioma typically experience recurrence, undergo multiple surgical resections, and ultimately have a poor prognosis. Thus far, effective chemotherapy for malignant meningiomas has not been established. We recently reported the efficacy of eribulin (Halaven) for glioblastoma with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.